ATC Abstracts

American Transplant Congress abstracts

  • Home
  • Meetings Archive
    • 2022 American Transplant Congress
    • 2021 American Transplant Congress
    • 2020 American Transplant Congress
    • 2019 American Transplant Congress
    • 2018 American Transplant Congress
    • 2017 American Transplant Congress
    • 2016 American Transplant Congress
    • 2015 American Transplant Congress
    • 2013 American Transplant Congress
  • Keyword Index
  • Resources
    • 2021 Resources
    • 2016 Resources
      • 2016 Welcome Letter
      • ATC 2016 Program Planning Committees
      • ASTS Council 2015-2016
      • AST Board of Directors 2015-2016
    • 2015 Resources
      • 2015 Welcome Letter
      • ATC 2015 Program Planning Committees
      • ASTS Council 2014-2015
      • AST Board of Directors 2014-2015
      • 2015 Conference Schedule
  • Search
  • 2018 American Transplant Congress

    Hard-To-Place Kidney Offers: Granular Examination of Donor Risk Factors for Discard

    R. Narvaez, J. Nie, K. Noyes, M. Leeman, L. Kayler.

    Dept of Surgery, University at Buffalo, Buffalo, NY; Dept of Epidemiology and Environmental Sciences, University at Buffalo, Buffalo, NY; Jacobs School of Medicine and Biomedical Sciences, University at Buffalo, Buffalo, NY.

    Background: Deceased-donor kidney discard rates remain high. Understanding risk factors for discard is difficult since most analyses lack granularity and sufficient sample of high disease…
  • 2018 American Transplant Congress

    Preemptive Plasma Therapy and Eculizumab (ECU) Rescue for Atypical Hemolytic Uremic Syndrome (aHUS) Relapse Following Kidney Transplantation (KTX)

    C. Aigner,1,2 G. Böhmig,1 F. Eskandary,1 M. Gaggl,1 R. Kain,2 R. Sunder-Plassmann,3 Z. Prohaszka,4 A. Schmidt,1 G. Sunder-Plassmann.1

    1Division of Nephrology and Dialysis, Medical University Vienna, Vienna, Austria; 2Clinical Institute of Pathology, Medical University Vienna, Vienna, Austria; 3Department of Laboratory Medicine, Medical University Vienna, Vienna, Austria; 43rd Department of Medicine, Semmelweis University, Budapest, Hungary.

    Introduction: KTX in aHUS patients is associated with a high rate of relapse and graft loss. Here, we report on seven aHUS cases with end-stage…
  • 2018 American Transplant Congress

    CMV and BKV Infections after Kidney Transplantation: Combined Tacrolimus/everolimus Strategy Using Antithymocyte Globulin Induction

    T. Jouve,1,4 R. Germi,2,4 B. Janbon,1 G. Fiard,3,4 P. Malvezzi,1 L. Rostaing.1,4

    1Nephrology, Dialysis, Apheresis, Transplantation Unit, Grenoble University Hospital, Grenoble, France; 2Virology Unit, Grenoble University Hospital, Grenoble, France; 3Urology Unit, Grenoble University Hospital, Grenoble, France; 4Medical Sciences, Grenoble University, Grenoble, France.

    Cytomegalovirus (CMV) and BK Virus (BKV) infections are frequent complications after kidney transplantation. A combined regimen of calcineurin inhibitor (CNI) and mTOR inhibitors (mTORi) reduces…
  • 2018 American Transplant Congress

    Novel Low Dosing of Rabbit Antithymocyte Globulin Preserves Excellent Outcomes and Improves the Value of Care in Low Risk Renal Transplantation

    J. Dann, W. Ally, M. Bradley, J. Geyston, A. Agarwal.

    University of Virginia Health System, Charlottesville, VA.

    Elderly and non-sensitized renal transplant patients may benefit from lesser induction immunosuppression. This study evaluates three year clinical outcomes of a low risk renal transplant…
  • 2018 American Transplant Congress

    Maternal and Fetal Outcomes in Living Kidney Donors in Korea

    H. Lee,1 K. Yoo,2 M. Yu,1 Y. Kim.1

    1Seoul National University, Seoul, Korea; 2Dongguk University College of Medicine, Gyeongju, Korea.

    Background. Mild elevation of blood pressure after unilateral nephrectomy may contribute to elevate gestational hypertension or preeclampsia in women donors. To date, impact of kidney…
  • 2018 American Transplant Congress

    Effects of Medication Education Pilot Program in Living versus Deceased Donor Kidney Transplant Recipients.

    N. Sulejmani, H. Albanna, B. Summers, A. Jantz, R. Prashar, A. Patel.

    Henry Ford Transplant Institute, Detroit, MI.

    Purpose: Medication adherence is crucial for transplant recipients as non-adherence can result in increased risk of rejection and graft loss. Early education prior to transplant…
  • 2018 American Transplant Congress

    Impact of Lymphoceles after Kidney Transplantation on Long-Term Outcomes

    L. Lehner, A. Hohberger, F. Halleck, E. Schrezenmeier, D. Khadzhynov, K. Budde, O. Staeck.

    Dept. of Nephrology and Medical Intensive Care, Charité Universitätsmedizin Berlin, Berlin, Germany.

    Introduction: Despite preventive methods, lymphoceles are common complications occurring in up to a third of kidney transplant recipients (KTR). A variety of risk factors (surgical,…
  • 2018 American Transplant Congress

    The Impact of Lymphocele Formation after Kidney Transplantation on De Novo Donor Specific Antibody Formation

    L. Lehner, A. Hohberger, F. Halleck, E. Schrezenmeier, K. Budde, O. Staeck, D. Khadzhynov.

    Dept. of Nephrology and Medical Intensive Care, Charité Universtitätsmedizin Berlin, Berlin, Germany.

    Introduction: Lymphocele formation is a common complication after kidney transplantation and has been linked to rejection episodes. However, long-term outcome data are scarce and the…
  • 2018 American Transplant Congress

    HLA Mismatching and cPRA Do Not Affect BK Viremia and Nephropathy Risk in Kidney Transplantation: A Retrospective Analysis

    B. Suleiman, S. Saleh, W. Hassan, K. Wang, A. Maibam, A. Karim, A. Hines, X. Mei, A. El-Husseini, M. Yaseen, V. Cornea, A. Castellanos, R. Gedaly, T. Waid.

    Nephrology, University of Kentucky, Lexington, KY.

    Introduction:Nephropathy from BK virus is a significant complication of kidney transplantation and occurs following a period of viremia. Patients who are HLA mismatched and more…
  • 2018 American Transplant Congress

    Long-Term Outcomes of Liver Transplantation in Patients with Pre-Transplant Renal Dysfunction Treated with Induction Therapy and Delayed Reduced De Novo Once-Daily Tacrolimus

    M. Gastaca,1 J. Bustamante,2 A. Ventoso,1 J. Fernandez,2 P. Ruiz,1 M. Testillano,2 M. Prieto,1 P. Salvador,2 I. Palomares,1 M. Senosiain,2 M. Suarez,2 A. Valdivieso.1

    1Hepatobiliary Surgery and Liver Transplant Unit, Cruces University Hospital, Bilbao, Spain; 2Hepatology Unit, Cruces University Hospital, Bilbao, Spain.

    AIM: To describe the long-term outcome of liver transplantation (LT) in patients with pre-transplant renal dysfunction treated with induction therapy and delayed reduced de novo…
  • « Previous Page
  • 1
  • …
  • 158
  • 159
  • 160
  • 161
  • 162
  • …
  • 211
  • Next Page »

Visit Our Partner Sites

American Transplant Congress (ATC)

Visit the official site for the American Transplant Congress »

American Journal of Transplantation

The official publication for the American Society of Transplantation (AST) and the American Society of Transplant Surgeons (ASTS) »

American Society of Transplantation (AST)

An organization of more than 3000 professionals dedicated to advancing the field of transplantation. »

American Society of Transplant Surgeons (ASTS)

The society represents approximately 1,800 professionals dedicated to excellence in transplantation surgery. »

Copyright © 2013-2025 by American Society of Transplantation and the American Society of Transplant Surgeons. All rights reserved.

Privacy Policy | Terms of Use | Cookie Preferences